Ubs Group Ag Incannex Healthcare LTD Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.11 - $2.11 $87 - $166	79 New	79 $0
Q4 2022 Feb 08, 2023	SELL	$2.72 - $4.76 $913 - $1,599	-336 Reduced 10.04%	3,011 $8,000
Q3 2022 Nov 10, 2022	BUY	$3.44 - $5.57 $7,619 - $12,337	2,215 Added 195.67%	3,347 $15,000
Q2 2022 Aug 10, 2022	SELL	$3.86 - $9.14 $6,272 - $14,852	-1,625 Reduced 58.94%	1,132 $4,000
Q1 2022 May 16, 2022	BUY	$9.16 - $35.5 $25,254 - $97,873	2,757 New	2,757 $25,000

Ticker IXHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 51,693,400
Market Cap $151M
Description
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.